AbbVie's market cap is currently $402.76B. The company's EPS TTM is $2.97; its P/E ratio is 108.50; and it has a dividend yield of 2.88%. AbbVie is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is $1.77. See an overview of income statement, balance sheet, and cash flow financials.
